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ABSTRACT
Objective: The objective of the present work was to formulate and evaluate ointment using sunflower wax.
Methods: In the present work, ointment formulations were prepared using sunflower wax by fusion technique. Sunflower wax base was compared 
with standard base for its pH, appearance, strength, spreadability, water number, and washability. Further, the optimized formulation was prepared 
with 2% salicylic acid and evaluated for its physicochemical parameters, compatibility study, drug content, in vitro drug diffusion, ex vivo permeability, 
and skin irritation test using rat skin.
Results: All of the prepared formulations of ointments were evaluated for its physicochemical parameters and all the findings obtained were within 
the prescribed limit. As compared to the ointment prepared by prototype formulae as per USP and IP, the formulation F3 containing 97% white 
petrolatum and 3% of sunflower wax showed good viscosity, strength, and spreadability. Based on viscosity, strength, and spreadability, formulation 
F3 was chosen as an optimized formulation.
Conclusion: The ointment consisting of white petroleum base 97% and 3% sunflower wax can be used for topical and systemic delivery of active 
ingredient salicylic acid. The results showed that sunflower wax can be used in ointment base as far as its pharmaceutical properties are concerned. 
It can effectively replace comparatively costlier available ointment bases.
Keywords: Ointment, Salicylic acid, Sunflower wax, Strength, Spreadability.
INTRODUCTION
A number of topical dermatologic products, ranging from solids to liquids, 
are available for the treatment of skin diseases [1,2]. Majority of ointments 
consist of a base, which mainly acts as a carrier or vehicle for the 
medicaments. The nature of the base also controls its performance; hence, 
selection of ointment base is a very important aspect of formulation [3]. 
Traditional ointment bases have been oleaginous in nature, which include 
hydrocarbons such as petrolatum, beeswax, and vegetable oils that do not 
allow inclusion of any water inversely to fatty alcohols. Ointments are used 
topically for several purposes such as protective, antiseptic, emollient, 
antipruritic, keratolytic, and astringent. The base of an ointment is of 
prime importance if the finished product is expected to function as any of 
the above categories. The ointment base composition determines not only 
the extent of penetration but also controls the transfer of medicaments 
from the base to the body tissues [3,4].
Many waxes such as white wax, carnauba wax, beeswax, and Candelilla 
wax are the natural waxes commonly used in cosmetic and pharmaceutical 
products [5]. Compared to these waxes, sunflower wax is cheap and 
obtained from natural source and is abundantly available. Sunflower wax 
is a hard, white crystalline, high melting point vegetable wax and is Ecocert 
Certified [6,7]. It is a component of the hull of sunflower (Helianthus 
annuus) oilseeds. The wax is composed of extensively saturated esters of 
long chain fatty acids (C20–C22) and fatty alcohols (C22–C29). It is often 
generated as a by-product of sunflower oil refinery and hence considered 
as of low economic value. It largely contains ceryl cerotate. It helps to 
thicken the formulation by providing a rigid structural network of wax 
crystals, improving oil binding, emolliency, film formation, and lubricity 
[8,9]. Therefore, an attempt has been made in the present study to utilize 
sunflower wax substituting beeswax in ointment bases with functional 
benefits in the formulation of ointments.
MATERIALS AND METHODS
Materials
The sunflower wax was obtained as a gift sample from M/s Mahesh Ltd., 
Mumbai, India. All other chemicals were used of analytical grade.
Methods
Compatibility study
The differential scanning calorimetry (DSC) thermograms of salicylic 
acid, sunflower wax, white petrolatum, and optimized formulation 
were recorded on DSC Lab: Mettler Instrument. For analysis, all samples 
(2–4 mg) were weighed accurately into a tared standard aluminum 
pans and sealed using an aluminum lid. Analysis was carried out over 
a temperature range of 0–240°C with a heating rate of 10°C/min in a 
nitrogen gas environment (30 mL/min) [10].
Preparation of ointment formulations
Two topical ointment bases of varying degrees of aqueous or 
anhydrous character, namely: simple ointment USP (T1) and simple 
ointment IP (T2) and formulations containing sunflower wax were 
prepared by fusion method [10-12]. In this method, the constituents 
of the base were placed together in a melting pan and allowed to melt 
together at 70°C. After melting, the ingredients were stirred gently 
maintaining temperature of 70°C for about 5 min and then cooled with 
continuous stirring to 40°C. Ointments were then stirred until a smooth 
consistency was obtained and stored at room temperature (25°C) 
and used for further analysis. Formulation of ointment containing 
2% salicylic acid was done by incorporating 2 g of the drug into the 
optimized formulation F3 by triturating on an ointment slab with 
spatula to obtain 100 g. The composition of all ointment formulations 
is presented in Table 1.
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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Evaluation of ointment
All the prepared ointments were characterized for the parameters such 
as appearance, odor, color, homogeneity, pH, spreadability, hardness, 
water number, and viscosity measurements.
Organoleptic characteristics
All blank formulations (i.e., formulations without active ingredient) and 
drug-loaded formulation were tested for physical appearance, color, 
texture, phase separation, and homogeneity. These characteristics were 
evaluated by visual observation. Homogeneity and texture were tested 
by pressing a small quantity of the formulated cream and gels between 
the thumb and index finger. The consistency of the formulations and 
the presence of coarse particles were used to evaluate the texture 
and homogeneity of the formulations. Immediate skin feel (including 
stiffness, grittiness, and greasiness) was also evaluated [13,14].
PH
About 2.5 g of all formulations were taken in dry beaker and 50 ml of 
water was added. Beaker containing ointments was heated on water 
bath at 60–70°C. The pH of ointments determined using a pH meter (pH 
Tutor, Eutech Instruments). The determinations were carried out in 
triplicate and the averages of three readings were noted.
Spreadability
Spreadability of the formulation was determined by an apparatus suggested 
by Multimer with some modifications [15]. It consists of a wooden block 
having a pulley at one end with fixed glass slide on block. An excess of 
ointment (3 g) placed on ground plate. The ointment was sandwiched 
between this plate and another glass plate having the dimension of fixed 
ground plate and provided with the hook. A 1 kg weight was placed on the 
top of the two plates for 5 min to expel air and to provide a uniform film 
of the ointment between the plates. Excess of ointment was scrapped off 
from the edges. The top plate was then subjected to pull of 240 g. With the 
help of spring attached to the hook and time required by the top plate to 
cover a distance of 10 cm was noted. A shorter interval indicates better 
spreadability. Spreadability was calculated using the following formula:
S = M×L/T
Where, S = Spreadability
M = Weight in the pan (tied to the upper slide)
L = Length moved by the glass slide and
T = Time (in seconds) taken to separate the slide completely each other.
Viscosity
Brookfield Synchro-Lectric Viscometer (Model RVT) with Helipath 
Stand was used for rheological studies. The sample (50 g) was placed 
in a beaker and was allowed to equilibrate for 5 min before measuring 
the dial reading using a T-D spindle at 10, 20, 30, 50, 60, and 100 rpm. 
At each speed, the corresponding dial reading on the viscometer 
was noted. The spindle speed was successively lowered and the 
corresponding dial reading was noted. The measurements were carried 
in triplicate at ambient temperature. Direct multiplication of the dial 
readings with factors given in the Brookfield Viscometer catalog gave 
the viscosity in centipoises (CPS).
Water number
Water number is the maximum amount of water that can be added to 
100 g of base at a given temperature. It was determined by continuously 
stirring the base with the addition of distilled water. When no more 
water was absorbed into the base evidenced by droplets of water, 
remaining in the container was taken as end point.
Hardness/strength
Hardness of formulations was determined using Texture Pro CT V1.3 
(Build 15 Brookfield Engineering Labs, Inc.) texture analyzer. It is based 
on the speed of the displacement of probe into sample (ointment) at a 
given distance. The probe was moving down at a speed of 2 mm/s till 
a 7 g surface trigger was attained. At this point, the probe was in full 
contact with the sample surface. Then, the probe continued to penetrate 
to a depth of 4 mm at a speed of 2 mm/s. At this point, the probe 
returned to its starting position. The penetration depth of a standard 
4 mm needle (P/2N) at a constant 10 kg load force was measured to 
represent the hardness of the formulation. The peak load (maximum 
force) was registered and is considered a measure of firmness of the 
product – the bigger the force the thicker/harder is the sample. All tests 
were conducted 2 times at room temperature (25±2°C) and values of 
peak force were expressed in g.
Drug content
Content of salicylic acid in the formulation was determined by diluting 
1 g of ointment equivalent to 2 mg of drug in 10 ml of ethanol and volume 
was made up to 100 ml with pH 7.4 phosphate buffer. Absorbance was 
measured at 275 nm using ultraviolet (UV)-visible spectrophotometer 
and percentage drug content was calculated and average of three 
determinations was noted (n=3) [12].
In vitro diffusion study
Franz diffusion cell was used for the drug release studies. Ointment 
was evenly applied onto the surface of cellulose membrane. The 
cellulose membrane was clamped between the donor and the receptor 
chamber of diffusion cell. The receptor compartment was filled with 
phosphate buffer pH 7.4, and the assembly was maintained at 37°C±0.5 
under constant magnetic stirring. With reference to Scale-up and 
Post-approval Changes guidelines laid by FDA, 300 mg of ointment 
was applied to the membrane on the donor compartment and then 
covered with aluminum foil to prevent drying out. Aliquots were 
withdrawn at predetermined time intervals over a period of 1 h and 
amount of salicylic acid released was analyzed at 275 nm using UV 
spectrophotometer [12,16,17].
Ex vivo permeation study
The rat skin was used by cleaning with a mild skin cleanser, removing 
any hair and subdermal fat and fascia were used. The prepared rat skin 
was mounted on the Franz diffusion cell (with effective diffusion area 
3.14 cm2 and 7 ml cell volume) with stratum corneum facing upward. 
The receptor compartment was filled with phosphate buffer pH 7.4, 
and the assembly was maintained at 37°C±0.5 under constant magnetic 
stirring. The amount of drug permeated through rat skin was carried 
out as per method described in diffusion study [16-18].
Table 1: Composition of ointment formulations containing sunflower wax
Ingredients (%) Formulation code
IP (T1) USP (T2) F1 F2 F3 F4 F5 F3 ‑ SA*
White petrolatum 85 95 95 96 97 98 99 97
White beeswax - 5 - - - - - -
Sunflower wax - - 5 4 3 2 1 3
Wool fat 5 - - - - - - -
Hard paraffin 5 - - - - - - -
Cetostearyl alcohol 5 - - - - - - -
*Optimized ointment formulation F3 with 2% salicylic acid
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Skin irritation study
Healthy albino rats of 25–30 g body weight were used for skin irritancy 
and sensitization model. The animals were housed in polypropylene 
cages and maintained under standard conditions (12 h light and dark 
cycles, at 22±2°C and 35–60% humidity). Standard palletized feed 
and tap water were provided ad libitum. The study was approved by 
the Institutional Animal Ethical Committee of R. C. Patel Institute of 
Pharmaceutical Education and Research, Shirpur, India, registered under 
Committee for the Purpose of Control and Supervision of Experiments 
on Animals (CPCSEA), India (registration No. 951/09/C/CPCSEA).
This test was performed on albino rats weighing between 150 and 
200 g. Animals are divided into four groups, each batch containing 
five animals. Dorsal hairs at the back of the rats were removed 1 day 
before the commencement of the study and kept individually in cages 
to avoid contact with the other rats. Optimized formulation F3-SA 
containing sunflower wax, USP (T1), and IP (T2) simple ointments was 
used to compare the skin irritation study on rats. Two groups of each 
were used for control and standard irritant. Other two groups were 
used as test. The 50 mg of each formulation were applied over one 
square centimeter area of whole and abraded skin of different animals. 
Aqueous solution of 0.8% formalin was used as standard irritant. At the 
end of the study, animal skin was evaluated for the skin irritancy and 
sensitization effect. The animals were observed for 7 days for any signs 
of edema and erythema. The photographs were taken and evaluated for 
the skin irritancy [19].
Stability testing
The developed ointment formulations were subjected to stability 
study as per the International Conference on Harmonization (ICH) 
guidelines. The formulated ointment was filled in the collapsible 
tubes and stored at different temperatures and humidity conditions, 
namely, 25°C±2°C /60%±5% RH, 30°C±2°C /65%±5% RH, and 
40°C±2°C /75%±5% RH for a period of 3 months and studied for 
appearance, pH, viscosity, and spreadability [19,20].
RESULTS AND DISCUSSION
Compatibility study
DSC analysis was performed for salicylic acid, sunflower wax, and 
optimized formulation F3-SA. DSC thermogram showed a distinct 
melting endotherm of drug and sunflower wax at 160°C and 80°C with 
an enthalpy value of −366.69 J/g and −1207.56 J/g, respectively. Figs. 1-3 
represent thermograms of salicylic acid, sunflower wax, and optimized 
formulation selected for the study. Melting endotherm of drugs was 
well preserved in most of the cases. For optimized formulation, in all 
the cases, melting endotherm of drug was well preserved with little or 
no change in enthalpy value of drug, indicating compatibility of drug 
with selected excipients in the study.
Physical evaluation of ointments
Organoleptic characteristics
The organoleptic properties, including physical appearance, color, 
texture, phase separation, homogeneity, and immediate skin feel of 
the ointment formulations, are shown in Table 2. Results showed that 
the ointments had a good appealing appearance and smooth texture, 
and they were all homogenous with no signs of phase separation. All 
formulations were white in color and aromatic odor.
pH
pH of all formulations was found to be between 6.80±0.152 and 
7.02±0.174 that is within the range, which are presented in Table 3. The 
pH of all formulations lies in the normal pH range of the skin.
Viscosity
Viscosity of all the formulations was noted and found in the range 
of 2314±6.13–2851±9.93 CPS at 10 rpm as shown in Table 3. All 
Fig. 1: Differential scanning calorimetry thermogram of salicylic acid
Fig. 2: Differential scanning calorimetry thermogram of sunflower wax
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the formulations were showed pseudoplastic flow. Average of three 
readings was calculated and standard deviation was determined (n=3).
Spreadability
Ointment spreadability can be categorized into three groups: Low, 
moderate, and high. After screening, it was found to be inversely 
proportional to the concentration of sunflower. As the amount 
of sunflower wax increased, the ointment became thicker, and, 
consequently, spreadability decreased. The spreadability of all 
formulations was determined and it was observed that formulation F3 
has greater spreadability as compared to other formulations as well as 
prototype formulations USP (T1) and IP (T2) as shown in Table 3.
Hardness
Hardness test is indicative of strength of ointment formulations and the 
results are found in the range of 122±5.03–243±4.13 g. It is observed 
that hardness of the ointment base formulated increases with increase 
in sunflower wax. This indicates that the proportion of the sunflower 
wax must be well controlled in the formulation for optimal hardness 
because when the product is too hard, spreadability will be difficult, 
and thus, the efficacy will be retarded. Optimized formulation F3 
showed closed strength such as prototype formulations USP (T1) and 
IP (T2) represented in Table 3.
In vitro drug diffusion study
The in vitro release profile using salicylic acid as model drug from 
ointment diffusion cell showed that 94.34% of drug was released at the 
end of 1 h represented in Fig. 4.
Ex vivo permeation study
The results of drug permeation through rat skin reveal that drug was 
released continuously through rat skin over a period of 1 h. The F3-
SA formulation with 3% of sunflower wax showed drug permeation of 
82.57±1.25 at the end of 1 h study represented in Fig. 5.
Skin irritation study
Optimized ointment formulation did not show any sign of erythema or 
edema when applied topically to the skin of animals during the study 
period. Formulation F3-SA and standard base formulations were found 
to be safe as they do not cause redness of skin and get score 0.
Stability study
All the ointment formulations were subjected to stability study as per 
ICH guidelines and results are shown in Table 4. During the stability 
studies, the appearance of formulations was clear and no significant 
variation in pH, spreadability, viscosity, and drug content for optimized 
formulation for the period of 3 months.
Fig. 3: Differential scanning calorimetry thermogram of optimized formulation F3‑SA







Homogeneity Immediate skin feel
USP (T1) Opaque Smooth No Homogeneous No grittiness or greasiness
IP (T2) Opaque Smooth No Homogeneous No grittiness or greasiness
F1 Opaque Rough and hard No Homogeneous No grittiness or greasiness
F2 Opaque Smooth No Homogeneous Little grittiness was observed and no greasiness
F3 Opaque Smooth No Homogeneous No grittiness or greasiness
F4 Opaque Smooth No Homogeneous No grittiness or greasiness
F5 Opaque Smooth No Homogeneous No grittiness or greasiness
F3 – SA* Opaque Smooth No Homogeneous No grittiness or greasiness
*Optimized ointment formulation F3 with 2% salicylic acid
Table 3: Evaluation parameters of ointment formulations
Formulation 
code 










USP (T1) 7.00±0.195 2456±6.53 97.32±4.53 128±4.50 1.1±0.14 -
IP (T2) 7.02±0.174 2489±8.95 102.91±5.03 148±6.93 1.5±0.16 -
F1 6.80±0.152 2851±9.93 80.00±3.83 243±4.13 1.2±0.25 -
F2 7.01±0.185 2612±8.13 109.09±5.13 220±3.90 1.3±0.08 -
F3 6.90±0.189 2472±7.23 112.57±4.23 157±3.83 1.3±0.12 -
F4 6.92±0.244 2412±8.03 110.16±3.53 138±4.13 1.4±0.10 -
F5 6.81±0.125 2314±6.13 115.91±5.12 122±5.03 1.3±0.08 -
F3–SA* 6.89±0.196 2470±7.33 102.91±4.13 154±5.83 1.4±0.19 99.63±4.10
#All values are mean±SD of three determinations. SD: Standard deviation. *Optimized ointment formulation F3 with 2% salicylic acid
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DISCUSSION
Prepared ointment formulations were subjected to various assessment 
parameters and the findings obtained were within the prescribed limits 
which are depicted in Tables 2 and 3. pH of all the formulations was 
found to be alkaline. All the formulations showed pseudoplastic flow on 
the basis of viscosity. The spreadability of formulation F3 is greater as 
compared to other formulations as well as the prototype formulations. 
It is seen that overall spreadability was improved by decreasing the 
concentration of sunflower wax. The formulation F3 prepared with 
sunflower wax was selected as optimized formulation on the basis of 
results of spreadability, viscosity, and hardness. The salicylic acid was 
used as model drug and incorporated in optimized formulation F3 
and showed promising results for in vitro drug diffusion and ex vivo 
permeation through cellulose membrane and rat skin, respectively. 
Formulation F3-SA was subjected to skin irritation study on rats showed 
no signs of redness when compared with standard base formulations 
USP (T1) and IP (T2) as shown in Fig. 6. Stability study indicates that 
optimized formulation is stable for the period of 3 months.
CONCLUSION
This study reveals that replacement of white beeswax with sunflower 
wax did not alter the properties of the simple ointment, thereby 
providing an economical alternative to beeswax. In general, we can say 
that sunflower wax is indigenous vegetable wax which is not commonly 
used so far but can successfully replace to other traditional natural hard 
waxes such as carnauba and beeswax in pharmaceutical and cosmetic 
products. It is seen that ointment containing a sunflower wax with active 
ingredient showed good strength, viscosity, and spreadability with no 
signs of skin irritation on rat skin. It also reduced the quantity of hard 
wax required in the ointment as compared to beeswax. Thus, it could 
be effective to incorporate sunflower wax in ointment formulations, 
to avail of its economical and functional benefits. It is anticipated, this 
work will encourage more research and faith toward utilization of 
natural active ingredients in pharmaceuticals.
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